必思諾b型腦膜炎雙球菌疫苗
荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - recombinant neisseria meningitidis group b nhba fusion protein (rp287-953);;recombinant neisseria meningitidis group b nada protein (rp961c);;recombinant neisseria meningitidis group b fhbp fusion protein (rp936-741);;outer membrane vesicles (omv) from neisseria meningitidis group b strain nz98/254 measured as amount of total protein containing the pora p1.4 - 懸浮注射液 - recombinant neisseria meningitidis group b nhba fusion protein (rp287-953) (8008004010) mcg; recombinant neisseria meningitidis group b nada protein (rp961c) (8008004020) mcg; recombinant neisseria meningitidis group b fhbp fusion protein (rp936-741) (8008004030) mcg; outer membrane vesicles (omv) from neisseria meningitidis group b strain nz98/254 measured as amount of total protein containing the pora p1.4 (8008004040) mcg - meningococcus b, multicomponent vaccine - 適用於2個月以上兒童及成人之主動免疫接種,以預防b型奈瑟氏腦膜炎雙球菌所引起的侵入性腦膜炎雙球菌疾病。
吸入用硫酸沙丁胺醇溶液 吸入溶液剂 5mg/2.5ml
glaxosmithkline australia pty ltd - 吸入溶液剂 - 5mg/2.5ml
流感病毒裂解疫苗 注射剂 15μg/各型/0.5ml/支
glaxosmithkline biologicals,branch of smithkline beecham pharma gmbh & co.kg - 注射剂 - 15μg/各型/0.5ml/支
拉莫三嗪片 片剂 100mg/片
glaxosmithkline australia pty ltd. - 片剂 - 100mg/片